blinatumomab,ponatinib
amgen,otsuka,astellas,incyte,takeda
['ponatinib', 'leukemia', 'blinatumomab', 'leusm']
combination ponatinib and blinatumomab produced durable responses in patients with newly diagnosed ph+ acute lymphoblastic leukemia in a phase 2 trial. #ash22 #leusm 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.